We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Get the latest from JAMA Dermatology
Please Wait... Processing your request... Please Wait.

Not a subscriber yet?

Subscribe to JAMA Dermatology for the latest peer-reviewed information on a broad range of issues relating to the skin and its conditions—clinical studies, surgical therapeutics, techniques, and breakthrough treatments. Subscribe/Learn More

JAMA Dermatology Tweets

Follow us on Twitter

Connect with us on Google+

Current Highlights

Follow Us

Original Investigation | November 25, 2015 ONLINE FIRST

Evaluation of Dermatology Practice Online Reviews

This qualitative research study characterizes common themes of reviews patients submitted to consumer review websites about their dermatologists and dermatology practices.

Original Investigation | November 18, 2015 FREE ONLINE FIRST

Safety and Efficacy of Anakinra in Severe Hidradenitis Suppurativa

This randomized clinical trial investigated the safety and efficacy of the anti-inflammatory biological therapy anakinra in 20 patients with Hurley stage II or III hidradenitis suppurativa.

Original Investigation | November 11, 2015 ONLINE FIRST

Cancer Stem Cell Biomarker CD133 in Cutaneous Squamous Cell Carcinoma

In this study, immunohistochemistry was performed on a tissue microarray to investigate the expression levels of cancer stem cell biomarker CD133 and its effect on clinicopathological features and outcomes in patients with cutaneous squamous cell carcinoma.

Original Investigation | November 4, 2015 ONLINE FIRST

Patient Risk Factors and Nevus-Associated Cutaneous Melanomas

This cohort study of patients with baseline nevi at higher risk for melanoma investigates the incidence of nevus-associated melanoma and clinical risk factors for those melanomas.

Original Investigation | October 28, 2015 ONLINE FIRST

Risk of Nonmelanoma Skin Cancer With Immunosuppressant Use

This cohort study characterizes the relative hazard of nonmelanoma skin cancer among patients with rheumatoid arthritis or inflammatory bowel disease exposed to methotrexate, anti–tumor necrosis factor therapy, or thiopurines after an initial nonmelanoma skin cancer.

Explore more articles:  Current Issue | Online First

Multimedia >

Author Interview

Author photo

Interview with Stanley Rockson, MD, author of The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema

audio player


The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema

All Author Interviews >

Article Video

Video thumbnail

Nasal Fiberoptic Endoscopy of the Larynx and Pharynx at Day 4 in a ... (00:57)

Findings include enanthema, edema and pseudomembranes of the epiglottis, and laryngeal vestibule enanthema without involvement of the vocal cords.

All Article Videos >


Interactive preview

All Interactive >

Author Readings
Author photo

audio player


Latest Quiz

All Quizzes >

Ulcerative Pretibial Lesions and Immunosuppression

A man in his 50s with a kidney transplant was admitted for a 1-month history of an enlarging left lower extremity mass that ulcerated, was occasionally painful, and drained small amounts of sanguinopurulent fluid.

What is your diagnosis?

JAMA Dermatology Patient Page

granuloma annulare

This month's Patient Information Page describes venous leg ulcers, a common form of chronic ulcer attributable to venous valvular insufficiency in the leg, and discusses how to improve blood flow and circulation to help heal these often-recalcitrant wounds.

JAMA Dermatology Patient Page Collection

Past JAMA Dermatology Patient Pages are available here. Topics include bullous pemphigoid, basal cell carcinoma, morphea (localized scleroderma), squamous cell carcinoma, cutaneous lupus erythematosus, and more.

Patient Identifiability in JAMA Dermatology

morphea Robinson et al highlight the importance of quality clinical photographs, patient consent forms, and patient privacy issues in submissions to JAMA Dermatology.

Image of JAMA forum logo

Instructions for Authors

Readers who wish to submit manuscripts for consideration by JAMA Dermatology are encouraged to carefully review the criteria for manuscript composition for each of the sections in JAMA Dermatology. The editorial office will not provide specific instructions in response to e-mail inquiries by authors. Authors will be referred to the Instructions for Authors.

Physician Jobs